1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. PAVmed Inc.
  6. News
  7. Summary
    PAVM   US70387R1068

PAVMED INC.

(PAVM)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
0.9959 USD   -5.15%
06/22PAVMED INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
06/21TRANSCRIPT : PAVmed Inc. - Shareholder/Analyst Call
CI
05/16PAVMED INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PAVMED INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

05/12/2022 | 05:29pm EDT

Item 2.02. Results of Operations and Financial Condition.

On May 12, 2022, PAVmed Inc. (the "Company") issued a press release announcing financial results for its fiscal quarter ended March 31, 2022 and providing a business update. A copy of the press release is attached to this report as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure.

The disclosure set forth under Item 2.02 is incorporated herein by reference.

The information furnished under Items 2.02 and 7.01, including the exhibit related thereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any disclosure document of the Company, except as shall be expressly set forth by specific reference in such document.

Item 9.01. Financial Statements and Exhibits.




  (d) Exhibits:



Exhibit No.   Description

99.1            Press release.

104           Cover Page Interactive Data File (embedded within the Inline XBRL
              document).

© Edgar Online, source Glimpses

All news about PAVMED INC.
06/22PAVMED INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission ..
AQ
06/21TRANSCRIPT : PAVmed Inc. - Shareholder/Analyst Call
CI
05/16PAVMED INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
05/13PAVmed and Lucid Diagnostics Chairman & CEO Lishan Aklog, M.D. Named Top 50 Healthcare ..
BU
05/12PAVMED INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Fin..
AQ
05/12PAVmed PAVmed Provides Business Update and Preliminary First Quarter 2022 Financial Res..
BU
05/12PAVmed Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/12TRANSCRIPT : PAVmed Inc., Q1 2022 Earnings Call, May 12, 2022
CI
05/04Lucid Diagnostics Selects Veeva Vault CDMS for EsoGuard® Study
PR
04/26PAVmed to Hold a Business Update Conference Call on May 12, 2022
BU
More news
Analyst Recommendations on PAVMED INC.
More recommendations
Financials (USD)
Sales 2022 3,56 M - -
Net income 2022 -76,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -1,14x
Yield 2022 -
Capitalization 87,6 M 87,6 M -
Capi. / Sales 2022 24,6x
Capi. / Sales 2023 5,46x
Nbr of Employees 89
Free-Float 89,5%
Chart PAVMED INC.
Duration : Period :
PAVmed Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PAVMED INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 1,00 $
Average target price 6,00 $
Spread / Average Target 502%
EPS Revisions
Managers and Directors
Lishan Aklog Chairman & Chief Executive Officer
Dennis M. McGrath President, Chief Financial Officer & Secretary
Brian J. deGuzman Chief Medical Officer & Executive Vice President
Shaun M. O’Neil Chief Operating Officer & Executive Vice President
Michael J. Glennon Vice Chairman
Sector and Competitors